Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Back to Forecasting
CLVT Forecast Markets
Clarivate PLC
7
Active Markets
51%
Avg Probability
All Markets
7 markets
Will Clarivate announce a completed sale of its Life Sciences & Healthcare segment by Q4 2026?
43%
Likely No
92% agreement
Jan 15, 2027
IG: 1.00
Will Clarivate achieve positive organic recurring revenue growth (>1%) for at least 2 consecutive quarters in FY2026?
45%
Likely No
92% agreement
Feb 28, 2027
IG: 0.80
Will Clarivate's IP segment achieve sustained positive ACV growth (>1%) by H2 2026?
36%
Likely No
93% agreement
Feb 28, 2027
IG: 0.64
Will Clarivate report AI product adoption by more than 6,000 institutions by Q4 2026?
57%
Likely Yes
93% agreement
Feb 28, 2027
IG: 0.64
Will Clarivate maintain renewal rates above 91% throughout FY2026?
80%
Likely Yes
96% agreement
Feb 28, 2027
IG: 0.60
Will Clarivate generate free cash flow above $400M in FY2026?
50%
Likely No
95% agreement
Feb 28, 2027
IG: 0.48
Will Clarivate report one-time and restructuring costs below $60M in FY2026?
43%
Likely No
93% agreement
Mar 31, 2027
IG: 0.48
Resolution Timeline
Jan 15, 2027
Will Clarivate announce a completed sale of its Life Sciences & Healthcare segment by Q4 2026?Prediction: 43%
Feb 28, 2027
Will Clarivate's IP segment achieve sustained positive ACV growth (>1%) by H2 2026?Prediction: 36%
Feb 28, 2027
Will Clarivate report AI product adoption by more than 6,000 institutions by Q4 2026?Prediction: 57%
Mar 31, 2027
Will Clarivate report one-time and restructuring costs below $60M in FY2026?Prediction: 43%